NCT05931458View on ClinicalTrials.gov

AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis

NANot yet recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2028

Conditions
Ulcerative Colitis
Interventions
PROCEDURE

Appendectomy

Laparoscopic appendectomy is a relatively simple surgical procedure that can be performedby most surgeons, either on an outpatient basis or with a single-night hospital stay. The laparoscopic approach is now the recommended option due to faster recovery times and fewer wound complications.

DRUG

Infliximab

Administration of Infliximab (Anti-TNF-a biologic drug)

All Listed Sponsors
collaborator

Crohn's and Colitis Foundation

OTHER

lead

Federico II University

OTHER

NCT05931458 - AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis | Biotech Hunter | Biotech Hunter